Details for New Drug Application (NDA): 020902
✉ Email this page to a colleague
The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. One hundred and forty-four suppliers are listed for this compound. Additional details are available on the famotidine profile page.
Summary for 020902
Tradename: | PEPCID AC |
Applicant: | J And J Consumer Inc |
Ingredient: | famotidine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020902
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 5, 1999 | TE: | RLD: | No |
Expired US Patents for NDA 020902
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 4,283,408*PED | ⤷ Subscribe |
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 5,854,267*PED | ⤷ Subscribe |
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 5,667,794*PED | ⤷ Subscribe |
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 4,820,524*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription